Roberta Serdoz

Showing 1-3 of 3 articles

Coronary interventions

Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions

Fam J, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis G, van Geuns R, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi G, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits P, Di Mario C, Seth A, Serra A, Colombo A, Serruys P, Galassi A, Zijlstra F, Van Mieghem N, Diletti R

June 20, 2017 | 10.4244/EIJ-D-16-00253

Coronary interventions

Coronary covered stents

Kilic D, Fabris E, Serdoz R, Caiazzo G, Foin N, Abou-Sherif S, Di Mario C

November 20, 2016 | 10.4244/EIJV12I10A210

Interventions for valvular disease

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Gilard M, Schlüter M, Snow T, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C

May 16, 2016 | 10.4244/EIJV12I1A15

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease